Nasdaq (Nasdaq: NDAQ) notified Platinum Analytics Cayman Limited (Nasdaq: PTLS) that its securities are expected to be delisted from the Nasdaq Stock Market on July 16, 2026, unless the company appeals to a Listing Qualifications Hearings Panel.
PTLS securities remain halted following a prior SEC trading suspension, and will stay unavailable for trading until any appeal is resolved. After removal from Nasdaq, the securities may be eligible for over-the-counter trading.
Loading...
Loading translation...
Positive
None.
Negative
Platinum Analytics Cayman Limited faces potential Nasdaq delisting on July 16, 2026
PTLS securities remain halted and unavailable to trade pending any appeal
Future trading may shift from Nasdaq to less liquid over-the-counter markets
News Market Reaction – NDAQ
-2.36%
-2.36%Session close to close
In the Jul 8 session, NDAQ declined 2.36%, reflecting a moderate negative market reaction.
Nasdaq’s move to delist Platinum Analytics after an SEC trading suspension underscores heightened re...
Analysis
Nasdaq’s move to delist Platinum Analytics after an SEC trading suspension underscores heightened regulatory scrutiny. Investors can compare this to other recent halt actions and monitor whether any appeal or over‑the‑counter quotation changes long‑term trading dynamics.
Key Figures
Nasdaq delisting date:July 16, 2026Nasdaq halt date:October 18, 2025
2 metrics
Nasdaq delisting dateJuly 16, 2026Planned removal of Platinum Analytics Cayman Limited securities from Nasdaq
Nasdaq halt dateOctober 18, 2025Start of Nasdaq trading halt following SEC temporary suspension
SpaceX addition to the Nasdaq‑100 Index effective before the July 7 open.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Pattern Detected
Recent Nasdaq headlines show mixed alignment between upbeat news and next‑day share moves, with both gains and declines following generally positive announcements.
"unless the company appeals to a Listing Qualifications Hearings Panel."
A listing qualifications hearings panel is a review board at a stock exchange that evaluates whether a company still meets the exchange’s rules for being listed, such as minimum share price, financial reporting, or governance standards. Think of it as a referee deciding if a team can stay in the league; its decisions can affect a stock’s ability to trade on the exchange, liquidity, investor confidence, and ultimately share value.
over-the-counter marketfinancial
"the securities may be eligible for trading in the over-the-counter market."
A market where securities are bought and sold directly between dealers and brokers instead of on a centralized stock exchange. Think of it like a neighborhood bazaar compared with a big supermarket: prices and rules can vary, oversight is lighter, and some instruments are harder to trade or riskier. Investors care because OTC listings can offer access to small or specialized investments but often come with higher price volatility, lower liquidity, and greater information risk.
temporary trading suspensionregulatory
"Following a temporary trading suspension in the Company’s securities by the U.S."
A temporary trading suspension is a short, planned halt in buying and selling a specific security imposed by an exchange or regulator. It is like hitting a pause button so the market can absorb important information, resolve extreme price swings, or fix technical or regulatory problems. For investors it matters because orders cannot be executed during the suspension, which pauses price discovery and liquidity and can create uncertainty about when trading will resume and at what price.
im-5101-4regulatory
"Nasdaq has now determined that it is appropriate to use its authority under IM-5101-4"
An investigational product code name for a drug or medical therapy under development and testing. Think of it as a prototype being evaluated in clinical studies to prove it works and is safe; positive or negative trial results, safety findings, or regulatory decisions about it can materially affect the developer’s future revenue prospects and share price. Investors watch such codes because they signal potential new products, timelines to market, and the level of scientific and regulatory risk involved.
NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market (Nasdaq: NDAQ) announced today that it has notified Platinum Analytics Cayman Limited (Nasdaq: PTLS) that its securities will be delisted from the Nasdaq Stock Market LLC on July 16, unless the company appeals to a Listing Qualifications Hearings Panel.The securities will remain halted, and unavailable to trade, until any appeal is resolved.Following removal from Nasdaq the securities may be eligible for trading in the over-the-counter market.
Following a temporary trading suspension in the Company’s securities by the U.S. Securities and Exchange Commission (https://www.sec.gov/files/litigation/suspensions/2025/34-104164-ts.pdf) Nasdaq halted trading in the Company’s ordinary shares on October 18, 2025.Nasdaq has now determined that it is appropriate to use its authority under IM-5101-4 to delist the Company’s securities from Nasdaq.
For news and additional information about the company, please review the companies’ public filings or contact the company directly.
Why is Platinum Analytics Cayman Limited (Nasdaq: PTLS) facing delisting from Nasdaq on July 16, 2026?
PTLS faces delisting because Nasdaq determined it appropriate to use its authority under IM-5101-4. According to Nasdaq, this decision follows an SEC temporary trading suspension and Nasdaq’s subsequent trading halt in PTLS ordinary shares that began on October 18, 2025.
What is the effective date of the anticipated Nasdaq delisting for Platinum Analytics Cayman Limited (PTLS)?
Nasdaq plans to delist PTLS securities on July 16, 2026, unless the company appeals. According to Nasdaq, a Listing Qualifications Hearings Panel review could change this timeline if Platinum Analytics Cayman Limited files a timely appeal of the delisting notice.
Can Platinum Analytics Cayman Limited (PTLS) appeal the Nasdaq delisting decision?
Yes, PTLS can appeal to a Nasdaq Listing Qualifications Hearings Panel before the delisting date. According to Nasdaq, PTLS securities will remain halted and unavailable to trade until any appeal process is fully resolved and a final determination has been made.
Will Platinum Analytics Cayman Limited (PTLS) be tradable after its removal from the Nasdaq Stock Market?
After removal from Nasdaq, PTLS securities may be eligible for trading in the over-the-counter market. According to Nasdaq, this potential OTC trading would occur only after the delisting is effective and would be separate from Nasdaq’s own listing and trading platforms.
Why are Platinum Analytics Cayman Limited (PTLS) shares currently halted on Nasdaq?
PTLS shares are halted on Nasdaq following an earlier SEC temporary trading suspension in the company’s securities. According to Nasdaq, it halted trading in PTLS ordinary shares on October 18, 2025, and those securities remain halted and unavailable to trade pending any appeal.
Where can investors find the Nasdaq rules governing the delisting of Platinum Analytics Cayman Limited (PTLS)?
Investors can review Nasdaq’s delisting rules in the Nasdaq Rule 5800 Series on the Nasdaq Listing Center website. According to Nasdaq, these rules describe the procedures, appeal rights, and criteria that apply when a security such as PTLS faces potential delisting.
